REVerse Intestinal Metaplasia in the Stomach (REVISE)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions

Gastric Intestinal MetaplasiaGastric Precancer

Interventions

DRUG

Pyrvinium

Pyrvinium (2 mg/kg) per day for 14 days

DRUG

Placebo

Placebo for 14 days

Trial Locations (1)

Duke Health, Durham

All Listed Sponsors

lead

Katherine Garman

OTHER